Spatial Bacterial Screening for Previously Undetected Antibiotics

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for discovering novel antibiotics have been inadequate, as traditional screening techniques have been overmined, and new approaches like culturing unculturable bacteria and AI-guided drug design have not fully addressed the need for effective antibiotic discovery.

Innovation Solution

A method involving streaking a first bacterial sample to form an internal space, allowing it to grow, spotting a second sample within this space, and harvesting a sample between the streaked and spotted locations to isolate potential antibiotics, leveraging intra-strain inhibition mechanisms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If traditional screening methods are used to discover antibiotics, then the process is simple and straightforward, but the effectiveness is reduced due to overmining of known antibiotic sources

Engineering Contradiction:
Improvesimplicity of screening processVSAvoideffectiveness of antibiotic discovery
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent applies preliminary action by pre-streaking the first bacterial sample to form an internal space before introducing the second bacterial sample. This preliminary configuration creates the necessary spatial arrangement for intra-strain inhibition to occur, enabling the detection of antibiotics that would otherwise remain undetected using conventional simultaneous inoculation methods

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent segments the screening process into distinct temporal and spatial phases: first streaking and growing the initial bacterial sample, then introducing the second sample at a later time point. This segmentation allows the system to detect antibiotics produced during the growth phase, separating the detection function from the traditional simultaneous inoculation approach

Inventive Principle:
Principle #1Segmentation

2Reliability

If new techniques like culturing unculturable bacteria or AI-guided design are used, then the potential for novel antibiotic discovery is improved, but the complexity and difficulty of implementation increases

Engineering Contradiction:
Improvepotential for novel antibiotic discoveryVSAvoidcomplexity of screening methodology
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs self-service by utilizing the bacteria's own growth and metabolic processes to produce and reveal the antibiotics. The intra-strain inhibition mechanism automatically identifies antibiotic production through the formation of borders between colonies, eliminating the need for complex external screening systems, unculturable bacteria techniques, or AI-guided design

Inventive Principle:
Principle #25Self-service

3Quantity of substance

If bacteria are allowed to grow for extended periods to produce antibiotics, then the yield of antibiotic compounds is improved, but the time required for screening increases

Engineering Contradiction:
Improveyield of antibiotic compoundsVSAvoidtime required for screening
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

The patent applies preliminary action by performing the initial streaking and growth phase before the second bacterial sample is introduced. This timing strategy allows the first bacteria to produce antibiotics during their growth phase, then the second sample is introduced to interact with these pre-produced antibiotics, reducing the total screening time while maintaining adequate antibiotic yield

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method reveals previously undetected antibiotics produced by bacteria, including broad-spectrum compounds like E. coli, which can inhibit the growth of other bacteria, including multi-drug resistant strains, through diffusible compounds.

Implementation Method 1

bacteria produce compounds to inhibit the growth of microbial competitors in their environment... mediated through the production of broad-spectrum secondary metabolites... resulting in the formation of a cell-free or low cell density border between the colonies

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS20250305022A1Methods of screening for antibiotics
Publication Date: 2025.10.02 RES FOUND THE CITY UNIV OF NEW YORK
  • US20250305022A1 patent drawing
  • US20250305022A1 patent drawing
  • US20250305022A1 patent drawing

AI summary

A method for screening for an antibiotic. A first bacterial sample is streaked to form an internal space that is surrounded by the streak. The streak is permitted to grow for at least 1 day. A second bacterial sample is spotted within the internal space and at least two days of growth time is permitted. A sample between the spotted location and streaked location is harvested and an antibiotic is harvested therefrom.